FIELD: medicine.
SUBSTANCE: invention relates to medicine. The method for the study of cholesterol metabolism includes the determination in the blood plasma of the content of low and very low density lipoprotein cholesterol (Cholldlc + Cholvldlc), high and very high density lipoprotein cholesterol (Cholldlc + Cholvldlc), hematocrit and circulating blood volume, in the evening before bedtime and in the morning on an empty stomach. Then the coefficient (C) is calculated, which makes it possible to assess the state of cholesterol metabolism. With a decrease in K indices in comparison with the normative ones: for men K equal to 1.12; for women - C equal to 1.20, evaluate the result as a violation of cholesterol metabolism.
EFFECT: invention improves reliability of the assessment of cholesterol metabolism.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR LIPOPROTEINS SYNTHESIS RESEARCH | 2015 |
|
RU2620553C1 |
| METHOD FOR STUDYING PROTEIN SYNTHESIS LIVER FUNCTION | 2015 |
|
RU2597765C1 |
| METHOD FOR STUDYING THE METABOLISM OF BILIRUBIN | 2021 |
|
RU2757156C1 |
| METHOD FOR EXAMINING LIVER DETOXIFICATION FUNCTION STATE | 2013 |
|
RU2537163C1 |
| METHOD FOR DIAGNOSING PATHOLOGICAL PATTERNS OF CLIMAX PERIOD | 1998 |
|
RU2164690C2 |
| METHOD OF PREDICTING RISK OF ADAPTATION FAILURE IN PEOPLE WORKING IN UNFAVORABLE CLIMATIC CONDITIONS OF ARCTIC | 2023 |
|
RU2810808C1 |
| ATHEROSCLEROSIS NUTRITIVE PREVENTION AND TREATMENT METHOD | 2007 |
|
RU2360669C1 |
| USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR CORRECTION OF METABOLIC DISORDERS | 2019 |
|
RU2768171C2 |
| METHOD OF INDIVIDUAL QUANTITATIVE ASSESSMENT OF ISCHEMIC HEART DISEASE DEVELOPMENT | 2012 |
|
RU2503405C1 |
| METHOD FOR PERFORMING HARDWARE PLASMAPHERESIS PROCEDURES WITH CIRCULATING PLASMA VOLUME REPLACEMENT FOR CORRECTING BIOLOGICAL AGE IN HEALTHY PEOPLE 40-55 YEARS OLD | 2022 |
|
RU2788817C1 |
